TWD 9.9
(-12.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -19.58 Million TWD | -258.68% |
2022 | 12.34 Million TWD | 1405.49% |
2021 | 820 Thousand TWD | 35.99% |
2020 | 603 Thousand TWD | 101.9% |
2019 | -31.75 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -7.11 Million TWD | 15.23% |
2024 Q2 | -7.11 Million TWD | 0.0% |
2023 Q3 | -8.39 Million TWD | -497.37% |
2023 Q1 | -1.4 Million TWD | -154.97% |
2023 FY | -19.58 Million TWD | -258.68% |
2023 Q2 | -1.4 Million TWD | 0.0% |
2023 Q4 | -8.39 Million TWD | 0.0% |
2022 Q4 | 2.55 Million TWD | 0.0% |
2022 FY | 12.34 Million TWD | 1405.49% |
2022 Q3 | 2.55 Million TWD | 0.0% |
2021 FY | 820 Thousand TWD | 35.99% |
2020 FY | 603 Thousand TWD | 101.9% |
2019 FY | -31.75 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 62.17% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 107.804% |
Level Biotechnology Inc. | 62.9 Million TWD | 131.141% |
Sagittarius Life Science Corp | -55.03 Million TWD | 64.409% |
NeoCore Technology Co., Ltd. | -64.64 Million TWD | 69.698% |
TaiMed Biologics Inc. | -194.81 Million TWD | 89.945% |
GlycoNex Incorporation | -178.36 Million TWD | 89.017% |
VBI | -6.6 Million TWD | -196.758% |
GeneReach Biotechnology Corp. | -166.27 Million TWD | 88.219% |
Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -83.383% |
SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 48.682% |
Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 88.344% |
Mycenax Biotech Inc. | -682.84 Million TWD | 97.131% |
Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 103.131% |
G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 127.057% |
Neith Corporation | -40.03 Million TWD | 51.068% |
Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 98.311% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -223.946% |
Enimmune corporation | -223.74 Million TWD | 91.245% |
TaiRx, Inc. | -212.29 Million TWD | 90.773% |
CHO Pharma, Inc. | -306.08 Million TWD | 93.6% |
EirGenix Inc. | -915.2 Million TWD | 97.86% |
BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 139.38% |
Sunny Pharmtech Inc. | -63.32 Million TWD | 69.063% |
Lin BioScience, Inc. | -687.19 Million TWD | 97.149% |
BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 87.469% |
Feng Chi Biotech Corp. | 22.79 Million TWD | 185.947% |
Bio Preventive Medicine Corp. | -73.28 Million TWD | 73.27% |
Lukas Biomedical Inc. | -47.35 Million TWD | 58.632% |
RBC Bioscience Corporation | 6.43 Million TWD | 404.65% |
BiOptic Inc. | 37.74 Million TWD | 151.896% |
BRIM Biotechnology, Inc. | -688.02 Million TWD | 97.153% |
Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 47.292% |
Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 68.169% |
Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 107.128% |
Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 78.733% |
NaviFUS Corp. | -65.72 Million TWD | 70.197% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 77.762% |
Sinew Pharma Inc. | -170.92 Million TWD | 88.539% |
Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 71.26% |
Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 114.992% |
Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 91.771% |
AP Biosciences Inc | -339.29 Million TWD | 94.227% |
Medigen Biotechnology Corp. | -561.29 Million TWD | 96.51% |
3D Global Biotech Inc. | -57.95 Million TWD | 66.197% |
Pharmosa Biopharm Inc. | 8.45 Million TWD | 331.658% |
Intech Biopharm Corporation | -337.98 Million TWD | 94.204% |
Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 98.508% |
Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 62.046% |
TWi Biotechnology, Inc. | -170.68 Million TWD | 88.523% |
Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 103.632% |
TCI GENE Inc. | 11.67 Million TWD | 267.815% |
MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 84.642% |
Senhwa Biosciences, Inc. | -296.3 Million TWD | 93.389% |
Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 90.994% |
NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 293.567% |
PharmaEngine, Inc. | 274.65 Million TWD | 107.132% |
Savior Lifetec Corporation | 30.03 Million TWD | 165.231% |
TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 114.327% |
OBI Pharma, Inc. | -1.04 Billion TWD | 98.128% |
Meribank Biotech Co., Ltd | -125.34 Million TWD | 84.372% |
Acepodia, Inc. | -817.31 Million TWD | 97.603% |
Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 95.99% |